As of Feb 12
| +0.04 / +0.71%|
The 1 analysts offering 12-month price forecasts for China Cord Blood Corp have a median target of 7.25, with a high estimate of 7.25 and a low estimate of 7.25. The median estimate represents a +26.97% increase from the last price of 5.71.
The current consensus among 1 polled investment analysts is to Hold stock in China Cord Blood Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.